GLP1R and obstructive sleep apnea syndrome: Pharmacological agents such as GLP-1 RAs, which promote substantial and sustained weight loss, may also mitigate OSA by reducing fat deposition around the upper airway, thereby decreasing soft tissue encroachment and airway resistance (111).